FCC's McDowell: "Golden Age of Wireless" ahead, and media impacts of a Dem victory
http://voices.washingtonpost.com/posttech/2008/10/chat_with_fccs_mcdowell_sees_m.html?wpisrc=newsletter ...
http://voices.washingtonpost.com/posttech/2008/10/chat_with_fccs_mcdowell_sees_m.html?wpisrc=newsletter ...
There may not be any human embryonic stem cell-derived therapies or cures, but that's understandable, according to columnist Tom Still. In this edition of Inside Wisconsin, he notes that the average drug takes 12 to 15 years to reach the market, so the lack of...
Washington, D.C. - The Center for Food Safety responded today to the United States Department of Agriculture's (USDA) new proposed regulations for the oversight of growing genetically engineered (GE) crops. In the Center's view, while stricter regulation of growing and field testing GE crops is needed,...
The Information Technology Association of Wisconsin is doing its part to slow the brain drain with its forthcoming launch of an online resource for student interns at the collegiate level. The Web-based service seeks to match interns with Wisconsin employers, and it will be available...
http://www.jsonline.com/watch/?watch=1&date=10/7/2008&id=47187 ...
Columnist Steven S. Clark, commenting on the controversial financial rescue plan, says we've got Congressmen and women right where we want them - running for re-election after voting to pass an unpopular bailout bill. In this edition of Biotech Takes, Clark also wonders what the...
To many, this question is a no-brainer, one answered with an emphatic yes, and columnist Michael Rosen is not about to argue. In this edition of Yer Biotech Blues, Rosen talks about the some of the changes proposed by former House Speaker Newt Gingrich to...
http://www.networkworld.com/news/2008/100608-can-spam.html?netht=ts_100608&nladname=100608dailynewspmal ...
Milwaukee, Wis. - MillerCoors has returned for the ninth consecutive year with its signature national business plan competition. Now called the MillerCoors Urban Entrepreneurs Series (MUES), the award-winning program is back and better than before, moving to Web 2.0, the next frontier in communication methods,...
Madison, Wis. - Quintessence Biosciences today announced the receipt of a Phase 1 Small Business Innovation Research contract from the National Cancer Institute to support the development of next generation drugs based on the EVade Ribonuclease (RNase) technology. This new class of drugs works...